Phase I Study of AZD2171 co-Administered With Fixed Multiple Oral Doses of ZD1839 in Patients With Advanced Cancer

Study to Assess the Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Efficacy of AZD2014

NCT01026402 ·Status: COMPLETED ·Phase: PHASE1

Study to Investigate the Management of Hypertension and Efficacy of AZD2171 in Patients With Advanced Solid Tumours

NCT00264004 ·Status: COMPLETED ·Phase: PHASE2

A Phase I Study of Safety, Tolerability, and PK of AZD2811 in Patients With Advanced Solid Tumors.

NCT02579226 ·Status: COMPLETED ·Phase: PHASE1

AZD8330 First Time in Man in Patients With Advanced Malignancies

NCT00454090 ·Status: COMPLETED ·Phase: PHASE1

Phase 1 PK Study of Cediranib in Single and Multiple Doses in Hepatically Impaired Patients With Solid Tumours

NCT00621725 ·Status: COMPLETED ·Phase: PHASE1

Phase I Orally Administered 14C-AZD2171 in Patients With Solid Metastatic Tumors

NCT00503412 ·Status: COMPLETED ·Phase: PHASE1

Safety, Tolerance, PK, and Anti-tumour Activity of AZD1775 Monotherapy in Patients With Advanced Solid Tumours

NCT02482311 ·Status: COMPLETED ·Phase: PHASE1

Safety, Tolerability and Pharmacokinetics of AZD1775 (Adavosertib) Plus MEDI4736 (Durvalumab) in Patients With Advanced Solid Tumours

NCT02617277 ·Status: COMPLETED ·Phase: PHASE1

AZD1152 in Patients With Advanced Solid Malignancies-Study 1

NCT00497731 ·Status: TERMINATED ·Phase: PHASE1

Phase I AZD2281/Cisplatin in Advanced Solid Tumour Patients

NCT00782574 ·Status: COMPLETED ·Phase: PHASE1

Study of AZD8931 in Patients With Advanced Solid Malignancies

NCT00637039 ·Status: COMPLETED ·Phase: PHASE1

A Phase I, Open-Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD6244 (ARRY-142886)

NCT00600496 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

First Time in Human Study of AZD8701 With or Without Durvalumab in Participants With Advanced Solid Tumours

NCT04504669 ·Status: COMPLETED ·Phase: PHASE1

Phase I, Open-label, Dose-escalation, Safety and PK Study of AZD6918

NCT00733031 ·Status: TERMINATED ·Phase: PHASE1

Phase Ib Study to Determine MTD of AZD1775 Monotherapy in Patients With Locally Advanced or Metastatic Solid Tumours.

NCT02610075 ·Status: COMPLETED ·Phase: PHASE1

Study for AZD4360 in Participants With Advanced Solid Tumours

NCT06921928 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Malignancies

NCT04644068 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2

Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies

NCT05417594 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

AZD6738 & Gemcitabine as Combination Therapy

NCT03669601 ·Status: UNKNOWN ·Phase: PHASE1

Safety, Tolerability & Potential Anti-cancer Activity of Increasing Doses of AZD5363 in Different Treatment Schedules

NCT01226316 ·Status: COMPLETED ·Phase: PHASE1

Absorption, Metabolism, Excretion and Pharmacokinetics of a Single Dose [14C]AZD2014 Followed by a Multiple Dose Phase

NCT02640755 ·Status: COMPLETED ·Phase: PHASE1

AZD0530 Study 21 - Phase I Study in Patients With Solid Tumours

NCT00704366 ·Status: COMPLETED ·Phase: PHASE1

AZD1152 in Patients With Advanced Solid Malignancies

NCT00338182 ·Status: COMPLETED ·Phase: PHASE1

Phase I, Open-Label, Dose-Escalation Study of AZD4877 in Solid Tumors

NCT00389389 ·Status: COMPLETED ·Phase: PHASE1

A Study to Provide Continued Access to and Assess Long-Term Safety of the Study Drug(s)

NCT06174987 ·Status: RECRUITING ·Phase: PHASE3